Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2004 2
2005 5
2006 3
2007 5
2008 5
2009 6
2010 10
2011 16
2012 7
2013 36
2014 20
2015 32
2016 33
2017 32
2018 36
2019 41
2020 32
Text availability
Article attribute
Article type
Publication date

Search Results

291 results
Results by year
Filters applied: . Clear all
Page 1
The Synaptic Vesicle Release Machinery.
Rizo J, Xu J. Rizo J, et al. Among authors: Xu J. Annu Rev Biophys. 2015;44:339-67. doi: 10.1146/annurev-biophys-060414-034057. Annu Rev Biophys. 2015. PMID: 26098518 Review.
UNC-18 and Tomosyn Antagonistically Control Synaptic Vesicle Priming Downstream of UNC-13 in Caenorhabditis elegans.
Park S, Bin NR, Yu B, Wong R, Sitarska E, Sugita K, Ma K, Xu J, Tien CW, Algouneh A, Turlova E, Wang S, Siriya P, Shahid W, Kalia L, Feng ZP, Monnier PP, Sun HS, Zhen M, Gao S, Rizo J, Sugita S. Park S, et al. Among authors: Xu J. J Neurosci. 2017 Sep 6;37(36):8797-8815. doi: 10.1523/JNEUROSCI.0338-17.2017. Epub 2017 Aug 8. J Neurosci. 2017. PMID: 28821673 Free PMC article.
Immunity duration of a recombinant adenovirus type-5 vector-based Ebola vaccine and a homologous prime-boost immunisation in healthy adults in China: final report of a randomised, double-blind, placebo-controlled, phase 1 trial.
Li JX, Hou LH, Meng FY, Wu SP, Hu YM, Liang Q, Chu K, Zhang Z, Xu JJ, Tang R, Wang WJ, Liu P, Hu JL, Luo L, Jiang R, Zhu FC, Chen W. Li JX, et al. Among authors: Xu JJ. Lancet Glob Health. 2017 Mar;5(3):e324-e334. doi: 10.1016/S2214-109X(16)30367-9. Epub 2016 Dec 23. Lancet Glob Health. 2017. PMID: 28017642 Free article. Clinical Trial.
Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
Zhu FC, Li YH, Guan XH, Hou LH, Wang WJ, Li JX, Wu SP, Wang BS, Wang Z, Wang L, Jia SY, Jiang HD, Wang L, Jiang T, Hu Y, Gou JB, Xu SB, Xu JJ, Wang XW, Wang W, Chen W. Zhu FC, et al. Among authors: Xu SB, Xu JJ. Lancet. 2020 Jun 13;395(10240):1845-1854. doi: 10.1016/S0140-6736(20)31208-3. Epub 2020 May 22. Lancet. 2020. PMID: 32450106 Free PMC article. Clinical Trial.
Learning about HIV the hard way: HIV among Chinese MSM attending university.
Zou H, Tucker JD, Fan S, Xu J, Yu M, Luo Z, Cai W, Grulich AE. Zou H, et al. Among authors: Xu J. Lancet Infect Dis. 2018 Jan;18(1):16-18. doi: 10.1016/S1473-3099(17)30711-9. Epub 2017 Dec 20. Lancet Infect Dis. 2018. PMID: 29303730 No abstract available.
Female and younger subjects have lower adherence in PrEP trials: a meta-analysis with implications for the uptake of PrEP service to prevent HIV.
Yun K, Xu JJ, Zhang J, Li JM, Hu QH, Chu ZX, Jiang YJ, Geng WQ, Shang H, Wang N. Yun K, et al. Among authors: Xu JJ. Sex Transm Infect. 2018 May;94(3):163-168. doi: 10.1136/sextrans-2017-053217. Epub 2017 Jul 29. Sex Transm Infect. 2018. PMID: 28756409 Review.
291 results
Jump to page